Cancer Research And Biostatistics (CRAB)
Emily Goren is a seasoned biostatistician currently serving as a Senior Biostatistician at Cancer Research And Biostatistics (CRAB) since October 2022. With prior experience as a Senior Biostatistician II at Seagen and a Data and Applied Scientist II at Microsoft, Emily has developed an extensive background in statistical modeling, data analysis, and research decision science. Notable achievements include providing statistical oversight for global health forecasting at the Institute for Health Metrics and Evaluation and validating Bayesian approaches for clinical trial safety monitoring at Merck. Emily holds a PhD in Statistics from Iowa State University and has also gained valuable teaching and research experience at various academic institutions and healthcare organizations.
This person is not in the org chart
Cancer Research And Biostatistics (CRAB)
1 followers
Cancer Research And Biostatistics (CRAB)® is a non-profit organization whose mission is to help conquer cancer, and other diseases. Since 1997, CRAB has supported over 300 clinical trials in partnership with foundations, universities, pharmaceutical and biotech companies. Past project experience has ranged from phase I to phase III, registration, staging, and prevention trials. CRAB provides a constellation of services that can help with concept creation, trial conduct, and regulatory submission or publication. Dr. Antje Hoering serves as President and CEO. Dr. John Crowley, co-founder with Dr. Cay Crowley, is Chairman of the Board of Directors. CRAB believes that collaboration accelerates outcomes. CRAB has long-standing partnerships with several cancer research organizations, including the SWOG Cancer Research Network, The Hope Foundation for Cancer Research, and SWOG Clinical Trials Partnerships. SWOG is one of five National Cancer Institute (NCI) supported members of the National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). CRAB and Fred Hutchinson Cancer Research Center make up the SWOG Statistics and Data Management Center (SDMC). CRAB is also an integral collaborator with the International Association for the Study of Lung Cancer (IASLC) since the late 1990s, publishing analysis for over 200,000 lung cancer cases in the 7th and 8th editions of the Staging Manuals. CRAB currently serves as the Independent Analysis Center for Friends of Cancer Research’s ctDNA for Monitoring Treatment Response (ctMoniTR) Project. In this project, CRAB receives data from the pharmaceutical and diagnostic partners, coordinates input from collaborators, harmonizes and pools data, and analyzes the pooled data to meet the project’s objectives. Message us to learn how we can support you in your next clinical trial, or partner with you, to continue to make strides in preventing and curing cancer.